Bluejay Diagnostics Statistics
Total Valuation
BJDX has a market cap or net worth of $1.76 million. The enterprise value is -$1.82 million.
Important Dates
The last earnings date was Thursday, May 7, 2026, after market close.
| Earnings Date | May 7, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
BJDX has 1.03 million shares outstanding. The number of shares has increased by 724.65% in one year.
| Current Share Class | 1.03M |
| Shares Outstanding | 1.03M |
| Shares Change (YoY) | +724.65% |
| Shares Change (QoQ) | +7.35% |
| Owned by Insiders (%) | 9.49% |
| Owned by Institutions (%) | 12.34% |
| Float | 844,450 |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.42 |
| P/TBV Ratio | 0.42 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.81, with a Debt / Equity ratio of 0.02.
| Current Ratio | 2.81 |
| Quick Ratio | 2.61 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -8,303.49 |
Financial Efficiency
Return on equity (ROE) is -171.56% and return on invested capital (ROIC) is -104.36%.
| Return on Equity (ROE) | -171.56% |
| Return on Assets (ROA) | -80.06% |
| Return on Invested Capital (ROIC) | -104.36% |
| Return on Capital Employed (ROCE) | -166.48% |
| Weighted Average Cost of Capital (WACC) | 7.82% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.15M |
| Employee Count | 6 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -76.12% in the last 52 weeks. The beta is 0.72, so BJDX's price volatility has been lower than the market average.
| Beta (5Y) | 0.72 |
| 52-Week Price Change | -76.12% |
| 50-Day Moving Average | 1.89 |
| 200-Day Moving Average | 4.37 |
| Relative Strength Index (RSI) | 40.30 |
| Average Volume (20 Days) | 24,348 |
Short Selling Information
The latest short interest is 21,481, so 2.08% of the outstanding shares have been sold short.
| Short Interest | 21,481 |
| Short Previous Month | 17,259 |
| Short % of Shares Out | 2.08% |
| Short % of Float | 2.54% |
| Short Ratio (days to cover) | 1.35 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -6.97M |
| Pretax Income | -6.90M |
| Net Income | -6.90M |
| EBITDA | -6.88M |
| EBIT | -6.97M |
| Earnings Per Share (EPS) | -$10.45 |
Full Income StatementBalance Sheet
The company has $3.68 million in cash and $97,032 in debt, with a net cash position of $3.59 million or $3.47 per share.
| Cash & Cash Equivalents | 3.68M |
| Total Debt | 97,032 |
| Net Cash | 3.59M |
| Net Cash Per Share | $3.47 |
| Equity (Book Value) | 4.18M |
| Book Value Per Share | 4.04 |
| Working Capital | 2.55M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$6.46 million and capital expenditures -$192,724, giving a free cash flow of -$6.65 million.
| Operating Cash Flow | -6.46M |
| Capital Expenditures | -192,724 |
| Depreciation & Amortization | 83,544 |
| Net Borrowing | -4,093 |
| Free Cash Flow | -6.65M |
| FCF Per Share | -$6.43 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
